Demand for enteral nutrition increased due to the high nutritional risks of the Covid-19 patients
PORTLAND, OR, UNITED STATES, September 22, 2021 /EINPresswire.com/ — An increase in number of malnutrition cases, growth in incidences of chronic illness, and high adoption of enteral nutrition over parenteral nutrition drive the growth of the global enteral nutrition market. Moreover, rise in geriatric population supplemented the market growth. However, poor demand in underdeveloped countries hinders the market growth. On the contrary, untapped potential in emerging market is expected to open lucrative opportunities for the market players in the future.
As per the report published by Allied Market Research, the global enteral nutrition market was pegged at $6.76 billion in 2018, and is estimated to reach $12.29 billion by 2027, growing at a CAGR of 7.1% from 2020 to 2028.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5049
Since the Covid-19 outbreak, the demand for enteral nutrition increased due to high nutritional risks of the Covid-19 patients. The Covid-19 patients require intensive care management and nutritional deficits caused during the condition. This offered opportunities for the market players.
However, the prolonged lockdown across various countries and temporary ban on international trade disrupted the supply chain.
The global enteral nutrition market is segmented on the basis of protein composition, age group, form, distribution channel, and region. Based on protein composition, the standard protein diet held the largest share in 2018, accounting for nearly three-fifths of the market. However, the protein for diabetes care patient segment is estimated to register the highest CAGR of 8.2% during the forecast period.
On the basis of distribution channel, the hospital sales segment dominated the market in 2018, contributing to more than three-fifths of the market. However, the online segment is projected to portray the highest CAGR of 7.9% during the forecast period.
The global enteral nutrition market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the lion’s share in 2018, accounting for around one-third of the market. However, Asia-Pacific is estimated to showcase the highest CAGR of 8.2% during the forecast period.
The global enteral nutrition market includes an in-depth analysis of the prime market players such as B. Braun Melsungen AG, Abbott Laboratories, Fresenius Kabi AG, Danone S.A., Hormel Foods Corporation, Global Health Products, Inc., Nestlé S.A., Meiji Holdings Co., Ltd., Reckitt Benckinser Group PLC, and Victus, Inc.
Animal Insulin Market: Global Opportunity Analysis and Industry Forecast, 2021–2030
Avian Influenza Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2021–2030
Carbinoxamine Market: Global Opportunity Analysis and Industry Forecast, 2021–2030
Source: EIN Presswire